Reducing tachycardia in septic shock patients: do esmolol and ivabradine have a chronotropic effect only?

An elevated heart rate (HR) often persists in resuscitated septic shock patients, increasing the risk of mortality. Several drugs for HR control, such as esmolol and ivabradine, have been tested in the recent years, but their benefit on the overall cardiovascular system is still under investigation. The aim of this study is to investigate the hemodynamic effects of the two drugs in a protocol of polymicrobial septic shock and resuscitation, mainly focusing on the vascular function. Twelve pigs were divided into three experimental groups: the esmolol-treated group (n=4), the ivabradine-treated group (n=5) and the control group (n=3). The characteristic arterial time constant τ was computed on aortic arterial pressure (AoP), together with estimates of total arterial compliance and peripheral resistance. Power spectral analysis of aortic and radial diastolic BP oscillations was performed to estimate the sympathetic autonomic control of vascular tone. Septic shock induced a severe cardiac and vascular disarray, only partially resolved by resuscitation. The administration of esmolol, but not ivabradine, was beneficial both for cardiac and vascular function, thereby its adjunction to standard therapies could help to improve patient’s condition and optimize the resuscitation strategies.Clinical Relevance-This study shows a potential beneficial effect of esmolol on the arterial tree

[1]  A. Kimmoun,et al.  If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock , 2016, Shock.

[2]  K. Werdan,et al.  Advances in the management of heart failure: the role of ivabradine , 2016, Vascular health and risk management.

[3]  Giuseppe Baselli,et al.  A Mathematical Model of dP/dt Max for the Evaluation of the Dynamic Control of Heart Contractility in Septic Shock , 2019, IEEE Transactions on Biomedical Engineering.

[4]  If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock , 2016, Shock.

[5]  Roger G. Mark,et al.  Continuous cardiac output monitoring by peripheral blood pressure waveform analysis , 2006, IEEE Transactions on Biomedical Engineering.

[6]  R. Bordet,et al.  A single endotoxin injection in the rabbit causes prolonged blood vessel dysfunction and a procoagulant state , 2000, Critical care medicine.

[7]  G. Baselli,et al.  Baroreflex Sensitivity and Blood Pressure Variability can Help in Understanding the Different Response to Therapy During Acute Phase of Septic Shock , 2017, Shock.

[8]  A. Kimmoun,et al.  &bgr;1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock* , 2015, Critical care medicine.

[9]  G. Baselli,et al.  Blood pressure variability, heart functionality, and left ventricular tissue alterations in a protocol of severe hemorrhagic shock and resuscitation , 2018, Journal of applied physiology.

[10]  Stefano Taddei,et al.  Sympathetic regulation of vascular function in health and disease , 2012, Front. Physio..

[11]  M. Pinsky,et al.  Peripheral vascular decoupling in porcine endotoxic shock. , 2011, Journal of applied physiology.

[12]  Martin W Dünser,et al.  Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress , 2009, Journal of intensive care medicine.

[13]  A. Wienke,et al.  Reducing Elevated Heart Rates in Patients with Multiple Organ Dysfunction Syndrome with The If (Funny Channel Current) Inhibitor Ivabradine , 2017, Shock.

[14]  M. Passariello,et al.  Tachycardia in Septic Shock: Pathophysiological Implications and Pharmacological Treatment , 2015 .